Ductal carcinoma in situ of the breast in men: A review

Clinical Breast Cancer

Volumn 6, Issue 4, 2005, Pages 310-314

  Pappo, Itzhak ^a   Wasserman, Ilan ^a   Halevy, Ariel ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

BRCA2 mutation; Intraductal carcinoma; Malignant neoplasm; Papillary carcinoma

Indexed keywords

BRCA2 PROTEIN;

ASPIRATION BIOPSY; BREAST CARCINOMA; BREAST DISCHARGE; BREAST DUCT; BREAST PAPILLOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MALE; MAMMOGRAPHY; MASTECTOMY; MORBIDITY; PAPILLARY CARCINOMA; PROGNOSIS; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 28344431582     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2005.n.033     Document Type: Review

References (62)

1. Millis RR, Hanby AM, Girling AC. The breast. In: Sternberg SS, ed. Diagnostic Surgical Pathology. 2nd ed. New-York: Raven Press; 1994:323-407.
2. Jemal A, Murray T, Ward E, et al. Cancer Statistics, 2005 [published erratum in CA Cancer J Clin 2005; 55:259]. CA Cancer J Clin 2005; 55:10-30.
3. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137:678-687.
4. Moore MP. Male breast cancer. In: Harris J, Lippman M, Morrow M, Osborne Ck, eds. Diseases of the Breast. Philadelphia: Lippincott Williams & Wilkins; 1996:859-863.
5. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53:538-549.
6. American Cancer Society. Cancer Facts & Figures 2005. Atlanta, GA: ACS; 2004.
7. Winchester DJ. Male breast carcinoma. Cancer 1998; 83:399-400.
8. Everson RB, Li FP, Fraumeni JF Jr, et al. Familial male breast cancer. Lancet 1976; 3:9-12.
9. Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84:1114-1117.
10. Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997; 60:313-319.
11. Ottini L, Masala G, D'Amico C, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003; 63:342-347.
12. Couch FJ, Farid LM, DeShano ML, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 1996; 13:123-125.
13. Thellenberg C, Malmer B, Tavelin B, et al. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003; 169:1345-1348.
14. Jackson AW, Muldal S, Ockey CH, et al. Carcinoma of the male breast in association with Klinefelter syndrome. Br Med J 1965; 5429:223-225.
15. El-Gazayerli MM, Abdel-Aziz AS. On Bilharziasis and male breast cancer in Egypt: a preliminary report and review of the literature. Br J Cancer 1963; 17:566-571.
16. Cohen R, Schauer PK. Male breast cancer following repeated fluoroscopy. Am J Med 1984; 76:929-930.
17. Olsson H, Bladstrom A, Alm P. Male gynecomastia and the risk for malignant tumors - a cohort study. BMC Cancer 2002; 2:26.
18. Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996; 77:490-498.
19. Guinee VF, Olsson H, Moller T, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 1993; 71:154-161.
20. Andre S, Fonseca I, Pinto AE, et al. Male breast cancer - a reappraisal of clinical and biologic indicators of prognosis. Acta Oncol 2001; 40:472-478.
21. Vetto J, Jun SY, Paduch D, et al. Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 1999; 177:379-383.
22. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137:678-687.
23. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma. Cancer 1999; 85:629-639.
24. Borgen PI, Senie RT, McKinnon WM, et al. Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann Surg Oncol 1997; 4:385-388.
25. Willsher PC, Leach IH, Ellis IO, et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res 1997; 17:2335-2388.
26. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 2003; 127:36-41.
27. Donegan WL, Redlich PN, Lang PJ, et al. Carcinoma of breast in males. Cancer 1998; 83:498-509.
28. Hittmair AP, Lininger RA, Tavassoli FA. Ductal carcinoma in situ (DCIS) in the male breast. Cancer 1998; 83:2139-2149.
29. Cole FM, Qizilbash AH. Carcinoma in situ of the male breast. J Clin Pathol 1979; 32:1128-1134.
30. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 1984; 2:903-909.
31. Camus MG, Joshi MG, Mackarem G, et al. Ductal carcinoma in situ of the male breast. Cancer 1994; 74:1289-1293.
32. Cutuli B, Dilhuydi JM, De Lafontan B, et al. Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer 1997; 33:35-38.
33. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275:913-918.
34. Borgen PI, Wong GY, Vlamis V, et al. Current management of male breast cancer. A review of 104 cases. Ann Surg 1992; 215:451-457.
35. Ouriel K, Lotze MT, Hinshaw JR. Prognostic factors of carcinoma of the male breast. Surg Gynecol Obstet 1984; 159:373-376.
36. Treves N, Holleb AI. Cancer of the male breast; a report of 146 cases. Cancer 1955; 8:1239-1250.
37. Norris HJ, Taylor HB. Carcinoma of the male breast. Cancer 1969; 23:1428-1435.
38. Vanderbilt PC, Warren SE. Forty year experience with carcinoma of the male breast. Surg Gynecol Obstet 1971; 133:629-633.
39. Heller KS, Rosen PP, Schottenfeld D, et al. Male breast cancer: a clinicopatho-logic study of 97 cases. Ann Surg 1978; 188:60-65.
40. Salvadori B, Saccozzi R, Manzari A, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1994; 30A:930-935.
41. Chinn K, Kalisher L, Rickert RR. Intracystic papillary in a 55-year-old man. J Can Assoc Radiol 1989; 40:40-42.
42. Hirschman SA, Hoda SA, May M, et al. Intraductal carcinoma in a male breast: diagnosis by nipple discharge cytology. Diagn Cytopathol 1995; 12:354-356.
43. Lopez-Rios F, Vargas-Castrillon J, Gonzalez-Palacios F, et al. Breast carcinoma in situ in a male. Report of a case diagnosed by nipple discharge cytology. Acta Cytol 1998; 42:742-744.
44. Simmons RM. Male ductal carcinoma in situ presenting as bloody nipple discharge: a case report and literature review. Breast J 2002; 8:112-114.
45. Inoue S, Kunitomo K, Okamoto H, et al. A case of male noninvasive intracystic papillary carcinoma forming a tumor in the nipple duct. Breast Cancer 2003; 10:85-88.
46. Ranieri E, D'Andrea MR, D'Alessio A, et al. Male breast carcinoma in situ. Report of a case diagnosed by nipple discharge cytology alone. Anticancer Res 1995; 15:1589-1592.
47. Deacon SJ, Walker RA, Rew DA. Ductal carcinoma in situ in the male breast presenting as a profuse watery nipple discharge: a case report. Europ J Surg Oncol 1997; 23:569.
48. Bodnar M, Miller OF 3rd, Tyler W. Paget's disease of the male breast associated with intraductal carcinoma. J Am Acad Dermatol 1999; 40:829-831.
49. Hayes R, Cummings B, Miller RA, et al. Male Paget's disease of the breast. J Cutan Med Surg 2000; 4:208-212.
50. Nakamura S, Ishida-Yamamoto A, Takahashi H, et al. Pigmented Paget's disease of the male breast: report of a case. Dermatology 2001; 202:134-137.
51. Sniege N, Holder PD, Katz RL, et al. Fine-needle aspiration cytology of the male breast in a cancer center. Diagn Cytopathol 1993; 9:691-697.
52. Fung A, Rayter Z, Fisher C, et al. Preoperative cytology and mammography in patients with single-duct nipple discharge treated by surgery. Br J Surg 1990; 77:1211-1212.
53. Simmons R, Adamovich T, Brennan M, et al. Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 2003; 10:11311-11316.
54. Wang Y, Abreau M, Hoda S. Mammary duct carcinoma in situ in males: pathological findings and clinical considerations. Mod Pathol 1997; 10:27A.
55. Winer EP, Morrow M, Osborne CK, et al. Malignant tumors of the breast. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001:1651-1717.
56. Deutsch M, Rosenstein MM. Ductal carcinoma in situ (DCIS) of the male breast treated by lumpectomy and breast irradiation. Clin Oncol (R Coll Radiol) 1998; 10:204-205.
57. Port ER, Fey JV Cody HS 3rd, et al. Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 2001; 91:319-323.
58. Stranzl H, Mayer R, Quehenberger F, et al. Adjuvant radiotherapy in male breast cancer. Radiother Oncol 1999; 53:29-35.
59. Ottini L, Masala G, D'Amico C, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003; 63:342-347.
60. Dershaw D. Male mammography. AJR 1986; 146:127-131.
61. Wolpert N, Warner E, Seminsky MF, et al. Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada. Clin Breast Cancer 2000; 1:57-63.
62. Brenner RJ, Weitzel JN, Hansen N, et al. Screening-detected breast cancer in a man with BRCA2 mutation: case report. Radiology 2004; 230:553-555.